Fixed-Dose Combination of Doravirine/Lamivudine/TDF is Non-Inferior to Efavirenz/Emtricitabine/TDF in Treatment-Naïve Adults With HIV-1 Infection: Week 48 Results of the Phase 3 DRIVE-AHEAD Study

  • Richard Kaplan

Press/Media

Period26 Jul 2017

Media coverage

1

Media coverage

  • TitleFixed-Dose Combination of Doravirine/Lamivudine/TDF is Non-Inferior to Efavirenz/Emtricitabine/TDF in Treatment-Naïve Adults With HIV-1 Infection: Week 48 Results of the Phase 3 DRIVE-AHEAD Study
    Media name/outletNational AIDS Treatment Advocacy Project
    Country/TerritoryUnited States
    Date26/07/17
    URLwww.natap.org/2017/IAS/IAS_27.htm
    PersonsRichard Kaplan